In vivo probing of purinergic P2X7 as a potential biomarker for suicide risk: a hypothesis - Summary - MDSpire

In vivo probing of purinergic P2X7 as a potential biomarker for suicide risk: a hypothesis

  • By

  • Henriëtte D. Heering

  • Lin Zhang

  • Dick Swaab

  • Elsmarieke van de Giessen

  • Christiaan H. Vinkers

  • Lot D. de Witte

  • Sander C.J. Verfaillie

  • June 24, 2026

  • 0 min

Share

Objective:

To propose an integrative neurobiological hypothesis linking childhood adversity and psychological pain to suicidality, while exploring the purinergic P2X7 receptor as a potential biomarker for assessing suicide risk.

Approach:
  • Neurobiological Hypothesis: The paper links childhood adversity to increased psychological pain and suicidality, proposing that dysregulation of the purinergic pathway, particularly the P2X7 receptor, contributes to these risks.
  • Ideation-to-Action Theory: The theory posits that psychological pain and hopelessness lead to suicidal ideation, while acquired capability enables the transition to suicidal behavior.
  • Mechanisms of P2X7 Dysregulation: The paper discusses three mechanisms through which P2X7 receptor overactivation may contribute to suicidality: neuroinflammation, glutamatergic dysregulation, and disruption of pain and fear circuits.
Key Findings:
  • Purinergic dysregulation is linked to increased risk for suicidal behavior, particularly in bipolar and depressive disorders and schizophrenia.
  • Postmortem findings indicate P2X7 dysregulation in individuals who died by suicide, independent of psychiatric diagnosis.
  • In vivo PET imaging can visualize the purinergic pathway and may help in developing biomarkers for acute suicidality.
Interpretation:

The findings suggest that psychological pain and childhood adversity are critical factors in suicidality, with the P2X7 receptor serving as a potential biomarker for assessing suicide risk.

Limitations:
  • The theoretical framework requires empirical validation through further research.
  • Current understanding of the purinergic pathway's role in suicidality is still developing.
Conclusion:

The study highlights the potential of the purinergic P2X7 receptor as a biomarker for suicidality.

Original Source(s)

Related Content